Fosinopril Sodium

福辛普利钠

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameFosinopril Sodium
Drug Alias Name福思普利VasoprilTensogard福新普利福辛昔利 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertensionHeart FailureHeart Diseases +[4] 
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryUnited States
Original Approved Date1991/05/16
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesSino--American Shanghai Squibb Pharmaceutical Ltd
Inactive CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)Bristol-Myers Squibb Company
Active IndicationsHypertensionHeart Failure
Inactive IndicationsHeart DiseasesCardiovascular Diseases

Other Information

ATC CodeC09AA09
Related LinksWikipediaDrugBankKEGG